Deborah H. Charych - 14 Feb 2023 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol
SKYE
Transactions as of
14 Feb 2023
Net transactions value
$0
Form type
3
Filing time
16 Feb 2023, 16:36:59 UTC
Next filing
03 Mar 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney.